Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Vladimir V. Kirkin"'
Autor:
Vladimir V. Kirkin, Victor I. Masychev, Leonid Z. Velsher, Emilia A. Kocharian, Michael L. Stachanov, Roman V. Zhashkov
Publikováno v:
SPIE Proceedings.
CO2-laser surgical systems have come to stay in everyday practice of modern physicians and are successfully used in colposcopic and laparoscopic surgery. Results, obtained in ambulance gynecology are especially impressing. CO2- laser provides high me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22f607374f2031ed85f9b8887d33b7df
https://doi.org/10.1117/12.403945
https://doi.org/10.1117/12.403945
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bianchi M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Reichen C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Croset A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Fischer S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Eggenschwiler A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Grübler Y; Molecular Partners AG, Zurich-Schlieren, Switzerland., Marpakwar R; Molecular Partners AG, Zurich-Schlieren, Switzerland., Looser T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Spitzli P; Molecular Partners AG, Zurich-Schlieren, Switzerland., Herzog C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Villemagne D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schiegg D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Abduli L; Molecular Partners AG, Zurich-Schlieren, Switzerland., Iss C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Neculcea A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Franchini M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Lekishvili T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Ragusa S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zitt C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Kaufmann Y; Molecular Partners AG, Zurich-Schlieren, Switzerland., Auge A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Hänggi M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Ali W; Molecular Partners AG, Zurich-Schlieren, Switzerland., Frasconi TM; Molecular Partners AG, Zurich-Schlieren, Switzerland., Wullschleger S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel I; Molecular Partners AG, Zurich-Schlieren, Switzerland., Matzner M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Lüthi U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Schlereth B; Molecular Partners AG, Zurich-Schlieren, Switzerland., Dawson KM; Molecular Partners AG, Zurich-Schlieren, Switzerland., Kirkin V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Grimm S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Reschke N; Molecular Partners AG, Zurich-Schlieren, Switzerland., Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Steiner D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Leupin N; Molecular Partners AG, Zurich-Schlieren, Switzerland., Goubier A; Molecular Partners AG, Zurich-Schlieren, Switzerland.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Jul 02; Vol. 12 (7), pp. 921-943.
Autor:
Hedayat S; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Cascione L; Bioinformatics Core Unit, Institute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, Bellinzona, Switzerland., Cunningham D; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Schirripa M; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Lampis A; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Hahne JC; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Tunariu N; Department of Radiology, The Royal Marsden Hospital, London and Sutton, United Kingdom., Hong SP; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Marchetti S; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Khan K; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Fontana E; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Angerilli V; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy., Delrieux M; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Nava Rodrigues D; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Procaccio L; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Rao S; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Watkins D; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Starling N; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Chau I; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Braconi C; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Fotiadis N; Department of Interventional Radiology, The Royal Marsden Hospital, London, United Kingdom., Begum R; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Guppy N; Breast Cancer Now Nina Barough Pathology Core Facility, The Institute of Cancer Research, London, United Kingdom., Howell L; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Valenti M; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Cribbes S; Revvity, Waltham, Massachusetts., Kolozsvari B; Sartorius, London, United Kingdom., Kirkin V; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Lonardi S; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Ghidini M; Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Passalacqua R; Oncology Unit, ASST Cremona, Cremona, Italy., Elghadi R; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Magnani L; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Pinato DJ; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Di Maggio F; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate Francesco Salvatore, Via Gaetano Salvatore, Naples, Italy., Ghelardi F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sottotetti E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vetere G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Ciracì P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Vlachogiannis G; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Cortellini A; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Loupakis F; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Fassan M; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy., Valeri N; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom.; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2140-2159.
Autor:
Harnden AC, Davis OA, Box GM, Hayes A, Johnson LD, Henley AT, de Haven Brandon AK, Valenti M, Cheung KJ, Brennan A, Huckvale R, Pierrat OA, Talbot R, Bright MD, Akpinar HA, Miller DSJ, Tarantino D, Gowan S, de Klerk S, McAndrew PC, Le Bihan YV, Meniconi M, Burke R, Kirkin V, van Montfort RLM, Raynaud FI, Rossanese OW, Bellenie BR, Hoelder S
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Apr 27; Vol. 66 (8), pp. 5892-5906. Date of Electronic Publication: 2023 Apr 07.
Autor:
Huckvale R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Harnden AC; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Cheung KJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Pierrat OA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Talbot R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Box GM; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Henley AT; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., de Haven Brandon AK; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hallsworth AE; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Bright MD; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Akpinar HA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Miller DSJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Tarantino D; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Gowan S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hayes A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Gunnell EA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Brennan A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Davis OA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Johnson LD; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., de Klerk S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., McAndrew C; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Le Bihan YV; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Meniconi M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Burke R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Kirkin V; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., van Montfort RLM; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Raynaud FI; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Rossanese OW; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Bellenie BR; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hoelder S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Jun 23; Vol. 65 (12), pp. 8191-8207. Date of Electronic Publication: 2022 Jun 02.
Autor:
Kocak M; Cancer Research UK, Cancer Therapeutics Unit, the Institute of Cancer Research London, Sutton, UK., Ezazi Erdi S; Fraunhofer ITMP ScreeningPort, Hamburg, Germany., Jorba G; Anaxomics Biotech SL, Barcelona, Spain., Maestro I; Centro De Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain., Farrés J; Anaxomics Biotech SL, Barcelona, Spain., Kirkin V; Cancer Research UK, Cancer Therapeutics Unit, the Institute of Cancer Research London, Sutton, UK., Martinez A; Centro De Investigaciones Biologicas 'Margarita Salas'-CSIC, Madrid, Spain.; Centro De Investigación Biomédica En Red En Enfermedades Neurodegenerativas (CIBERNED), Instituto De Salud Carlos III, Madrid, Spain., Pless O; Fraunhofer ITMP ScreeningPort, Hamburg, Germany.
Publikováno v:
Autophagy [Autophagy] 2022 Mar; Vol. 18 (3), pp. 473-495. Date of Electronic Publication: 2021 Jul 09.
Autor:
Milton CI; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Selfe J; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Aladowicz E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Man SYK; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Bernauer C; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Missiaglia E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Walters ZS; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Gatz SA; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kelsey A; Department of Paediatric Histopathology, Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital, UK., Generali M; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Box G; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Valenti M; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., de Haven-Brandon A; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Galiwango D; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Hayes A; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Clarke M; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Izquierdo E; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Gonzalez De Castro D; Molecular Haematology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Raynaud FI; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kirkin V; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Shipley JM; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Mar; Vol. 16 (6), pp. 1272-1289. Date of Electronic Publication: 2021 Dec 18.
Autor:
Carotenuto P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.; TIGEM - Telethon Institute of Genetics and Medicine, Naples, Italy., Amato F; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Lampis A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Rae C; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hedayat S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Previdi MC; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Zito D; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Raj M; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Guzzardo V; Department of Medicine, University of Padua, Padua, Italy., Sclafani F; The Royal Marsden NHS Trust, London and Surrey, London, UK., Lanese A; The Royal Marsden NHS Trust, London and Surrey, London, UK., Parisi C; The Royal Marsden NHS Trust, London and Surrey, London, UK., Vicentini C; ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, , University of Verona, Verona, Italy., Said-Huntingford I; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Hahne JC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Hallsworth A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kirkin V; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Young K; The Royal Marsden NHS Trust, London and Surrey, London, UK., Begum R; The Royal Marsden NHS Trust, London and Surrey, London, UK., Wotherspoon A; The Royal Marsden NHS Trust, London and Surrey, London, UK., Kouvelakis K; The Royal Marsden NHS Trust, London and Surrey, London, UK., Azevedo SX; The Royal Marsden NHS Trust, London and Surrey, London, UK., Michalarea V; The Royal Marsden NHS Trust, London and Surrey, London, UK., Upstill-Goddard R; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Rao S; The Royal Marsden NHS Trust, London and Surrey, London, UK., Watkins D; The Royal Marsden NHS Trust, London and Surrey, London, UK., Starling N; The Royal Marsden NHS Trust, London and Surrey, London, UK., Sadanandam A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Chang DK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Biankin AV; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.; South Western Sydney Clinical School, Faculty of Medicine, University of NSW, Sydney, NSW, Australia., Jamieson NB; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Scarpa A; ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, , University of Verona, Verona, Italy., Cunningham D; The Royal Marsden NHS Trust, London and Surrey, London, UK., Chau I; The Royal Marsden NHS Trust, London and Surrey, London, UK., Workman P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Fassan M; Department of Medicine, University of Padua, Padua, Italy.; Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy., Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Trust, London and Surrey, London, UK., Braconi C; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK. chiara.braconi@glasgow.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. chiara.braconi@glasgow.ac.uk.; The Royal Marsden NHS Trust, London and Surrey, London, UK. chiara.braconi@glasgow.ac.uk.; Beatson West of Scotland Cancer Centre, Glasgow, UK. chiara.braconi@glasgow.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Nov 18; Vol. 12 (1), pp. 6738. Date of Electronic Publication: 2021 Nov 18.
Autor:
Wesch N; Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe-University Frankfurt, 60438 Frankfurt am Main, Germany., Kirkin V; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research London, Sutton SM2 5NG, UK., Rogov VV; Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe-University Frankfurt, 60438 Frankfurt am Main, Germany.; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe-University Frankfurt, 60438 Frankfurt am Main, Germany.; Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, 60438 Frankfurt am Main, Germany.
Publikováno v:
Cells [Cells] 2020 Sep 01; Vol. 9 (9). Date of Electronic Publication: 2020 Sep 01.